Hedge Fund Drops Million: Beam Biotech Bet Right Now
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Index levels reveal trends and potential turns in markets. This quick overview shows what index level tells you and how to apply it to decisions.
23,042 articlesA major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
A major institutional move grabs attention as landmark investment partners cuts its stake in Howard Hughes Holdings. ...
When prominent athletes face controversy, the financial implications go beyond contracts. This piece explores how Adr...
A Sea Limited executive sold $4.4 million in stock but remains one of the company’s biggest stakeholders. This piece ...
A Franklin Electric insider sold 1,900 shares for about $190k, prompting questions about FELE. This guide explains in...
SpaceX’s public debut grabbed headlines, but history shows big early gains often fade. This guide explains why waitin...
Investors watch Nvidia for AI-driven gains, especially around key events. This guide uses history, data, and real-lif...
Cathie Wood goes bargain isn’t a hype moment. It’s a disciplined approach to re-evaluating disrupted growth names aft...
Explore how Fluent's Q1 2026 earnings could shape its year ahead. This article breaks down revenue trends, margins, a...
When a professional advisor exits a stake in TREX, it can signal shifts in strategy or risk controls. This guide brea...
When a CEO exits at a major fintech-adjacent firm, investors scramble for context. This article digs into what the de...
The Federal Reserve's stress tests gave America's biggest banks a green light, and lenders quickly rewarded sharehold...